Clinical Trial Update: Kanglaite Injection Phase I Study [Phase 1]

View source ↗

Summary

An update on a Phase I trial of Kanglaite Injection for solid tumors refractory to standard therapy, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• Kanglaite Injection (Kanglaite)

Snippet

Sponsor: KangLaiTe USA | Conditions: Solid Tumors Refractory To Standard Therapy, Neoplasms | Phase 1 | Status: COMPLETED